Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Psychometric Evaluation Supports Use of RiiQ Symptoms Scales in RSV Trials
07/19/2023
Jolynn Tumolo
In this study, the psychometric properties of the Respiratory Infection Intensity and Impact Questionnaire (RiiQ) were evaluated to test reliability and validity for use in clinical studies.
In this study, the psychometric properties of the Respiratory Infection Intensity and Impact Questionnaire (RiiQ) were evaluated to test reliability and validity for use in clinical studies.
In this study, the psychometric...
07/19/2023
Pharmacy Learning Network
News
Nonmotor Symptoms Feed Fear of Falling in Patients With Parkinson Disease
07/19/2023
Jolynn Tumolo
“Nurses should approach patients with Parkinson disease with a focus not only on assessing motor symptoms but also on assessing nonmotor symptoms,” said researchers. 
“Nurses should approach patients with Parkinson disease with a focus not only on assessing motor symptoms but also on assessing nonmotor symptoms,” said researchers. 
“Nurses should approach patients...
07/19/2023
Annals of Long-Term Care
News
Clinics Integrating Digital Therapeutics for Alcohol Use Should Expect High Demand
07/19/2023
Jolynn Tumolo
“Participants were enthusiastic about digital therapeutics for alcohol use disorder, anticipated high patient demand for such a resource, and made suggestions for successful implementation," researchers said.
“Participants were enthusiastic about digital therapeutics for alcohol use disorder, anticipated high patient demand for such a resource, and made suggestions for successful implementation," researchers said.
“Participants were enthusiastic...
07/19/2023
First Report Managed Care
Polygenic Score for ALS Reflects an Individual’s Cumulative Genetic Risk
News
Polygenic Score for ALS Reflects an Individual’s Cumulative Genetic Risk
07/18/2023
Jolynn Tumolo
A novel scoring system may help predict a person’s risk of developing amyotrophic lateral sclerosis (ALS) by weighing the combined effects of common genetic variants, according to a study published online in Neurology Genetics. “This...
A novel scoring system may help predict a person’s risk of developing amyotrophic lateral sclerosis (ALS) by weighing the combined effects of common genetic variants, according to a study published online in Neurology Genetics. “This...
A novel scoring system may help...
07/18/2023
Neurology
News
Medicare Could Save $1 Billion by Considering Added Benefit of Expensive Part B Drugs
07/18/2023
Jolynn Tumolo
Researchers find that Medicare could potentially save $1 billion by considering the added therapeutic benefit of expensive Part B drugs and implementing reference pricing.
Researchers find that Medicare could potentially save $1 billion by considering the added therapeutic benefit of expensive Part B drugs and implementing reference pricing.
Researchers find that Medicare...
07/18/2023
First Report Managed Care
A child sleeps with their hand tucked under their head
News
Persistent Nightmares in Childhood Linked With Cognitive Impairment, Parkinson Disease Development
07/18/2023
Jolynn Tumolo
Having persistent distressing dreams in middle childhood was associated with an 85% increased risk of developing cognitive impairment or Parkinson disease by age 50 compared with never having distressing dreams.
Having persistent distressing dreams in middle childhood was associated with an 85% increased risk of developing cognitive impairment or Parkinson disease by age 50 compared with never having distressing dreams.
Having persistent distressing...
07/18/2023
Neurology
News
Ophthalmic Drop Improves Signs, Symptoms of Dry Eye Disease in Phase 3 Trial
07/17/2023
Jolynn Tumolo
“There are currently no FDA-approved, prescription pharmacologic treatments for dry eye disease associated with meibomian gland dysfunction,” researchers wrote, “and the results of this study suggest that NOV03 may potentially fulfill this...
“There are currently no FDA-approved, prescription pharmacologic treatments for dry eye disease associated with meibomian gland dysfunction,” researchers wrote, “and the results of this study suggest that NOV03 may potentially fulfill this...
“There are currently no...
07/17/2023
First Report Managed Care
News
Type 2 Inflammation Linked With Persistent Allergic Disease
07/14/2023
Jolynn Tumolo
“Identifying individuals at risk for continued rhinitis and asthma allows clinicians to better plan follow-up appointments and improve the selection of patients who might benefit from allergen immunotherapy or treatments targeting type 2...
“Identifying individuals at risk for continued rhinitis and asthma allows clinicians to better plan follow-up appointments and improve the selection of patients who might benefit from allergen immunotherapy or treatments targeting type 2...
“Identifying individuals at risk...
07/14/2023
First Report Managed Care
News
Muscle Relaxants Recalled
07/14/2023
Jolynn Tumolo
Two firms issued recalls for tizanidine tablets after the product’s manufacturer, Dr Reddy’s Laboratories, recalled the tablets for failing to meet stability specifications.
Two firms issued recalls for tizanidine tablets after the product’s manufacturer, Dr Reddy’s Laboratories, recalled the tablets for failing to meet stability specifications.
Two firms issued recalls for...
07/14/2023
Pharmacy Learning Network
News
Epcoritamab Shows Durable Response in Relapsed/Refractory Large B-Cell Lymphoma
07/14/2023
Jolynn Tumolo
“The observed high response rates with durability in patients with refractory large B-cell lymphoma treated with epcoritamab, including postchimeric antigen receptor-T therapy, represent further evidence of the value of bispecific antibodies...
“The observed high response rates with durability in patients with refractory large B-cell lymphoma treated with epcoritamab, including postchimeric antigen receptor-T therapy, represent further evidence of the value of bispecific antibodies...
“The observed high response...
07/14/2023
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use